Conti R M, Meltzer D O, Ratain M J
Department of Pediatrics, Section of Pediatric Hematology/Oncology, Center on Health and the Social Sciences, Program on Pharmaceutical Policy, Cancer Research Center, The University of Chicago, Chicago, Illinois, USA.
Clin Pharmacol Ther. 2008 Aug;84(2):194-7. doi: 10.1038/clpt.2008.123.
Nonprofit biomedical firms are an integrated market-based solution to improve incentives for investment in promising scientific areas that have high social value but minimal potential for profit. We briefly review the current market with an emphasis on the financing of innovative product development and propose ideas for new nonprofit companies centered on the health concerns of developed countries. We conclude with a suggestion that opportunities exist for nonprofit firms focused on cancer diagnostics, given the limitations of current financing incentives and ripe scientific opportunity.
非营利性生物医学公司是一种基于市场的综合解决方案，旨在改善对具有高社会价值但盈利潜力极小的有前景科学领域的投资激励。我们简要回顾当前市场，重点关注创新产品开发的融资情况，并针对以发达国家健康问题为核心的新型非营利性公司提出想法。鉴于当前融资激励的局限性和成熟的科学机遇，我们得出结论，专注于癌症诊断的非营利性公司存在机会。
